AI assistant
REGENXBIO Inc. — Director's Dealing 2017
Sep 19, 2017
32827_dirs_2017-09-19_147aed6d-3007-4ad1-96b2-3a1e1363d567.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2017-09-15
Reporting Person: Vasista Vittal (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-15 | Common Stock | S | 2689.00 | $27.08 | Disposed | 99594.00 | Direct |
| 2017-09-15 | Common Stock | S | 2311.00 | $27.74 | Disposed | 97283.00 | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2: This transaction was executed in multiple trades at prices ranging from $26.55 to $27.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $27.55 to $28.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.